Swiss Dermatology Network of Targeted Therapies (SDNTT)

Recruiting now

Conditions studied: Psoriasis

In brief

The purpose of this study is to evaluate the long-term course of patients with psoriasis and psoriatic-arthritis in systemic treatments such as, methotrexate, cyclosporin A, fumaric acids, acitretin, systemic PUVA, etanercept, infliximab, adalimumab and ustekinumab. A patient will be included at first initiation of the treatment and will remain in the registry for 10 years, regardless of subsequent therapy. The registry will also evaluate safety clinical outcomes and health related quality of life.

Key facts

Study ID
NCT01706692
Run by
Swiss Dermatology Network for Targeted Therapies
People needed
1121
Starts
2011-02-01
Expected to finish
2032-03-15
Last updated by the study team
2024-11-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.